Literature DB >> 21160227

A gut feeling on endotoxemia: causes and consequences in chronic kidney disease.

Aline B Hauser1, Andréa E M Stinghen, Simone M Gonçalves, Sergio Bucharles, Roberto Pecoits-Filho.   

Abstract

Chronic inflammation is closely linked to several complications of chronic kidney disease (CKD), such as vascular calcification, accelerated atherosclerosis, loss of appetite, insulin resistance, increased muscle catabolism and anemia. As a consequence, inflammation is a predictor of mortality in this group of patients. Specific causes of the activation of the immune system in CKD are largely unknown. Endotoxin (ET) release to the circulation represents a potentially important target for interventions aiming to reduce mortality in CKD patients. In this minireview, we propose that there are several potential sources of endotoxemia in CKD and that gut translocation, leading to the generation of ligands of the innate immune response, represents a potentially reversible cause. Prevention of endotoxemia, through treating foci of ET (periodontal disease, catheters, vascular access) or reducing translocation from the gut, will potentially reduce the inflammatory response.
Copyright © 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2010        PMID: 21160227     DOI: 10.1159/000321438

Source DB:  PubMed          Journal:  Nephron Clin Pract        ISSN: 1660-2110


  13 in total

1.  Effect of phosphate binders on serum inflammatory profile, soluble CD14, and endotoxin levels in hemodialysis patients.

Authors:  Juan F Navarro-González; Carmen Mora-Fernández; Mercedes Muros de Fuentes; Javier Donate-Correa; Violeta Cazaña-Pérez; Javier García-Pérez
Journal:  Clin J Am Soc Nephrol       Date:  2011-07-22       Impact factor: 8.237

2.  Does the Administration of Sevelamer or Nicotinamide Modify Uremic Toxins or Endotoxemia in Chronic Hemodialysis Patients?

Authors:  Aurelie Lenglet; Nicolas Fabresse; Méline Taupin; Cathy Gomila; Sophie Liabeuf; Said Kamel; Jean Claude Alvarez; Tilman B Drueke; Ziad A Massy
Journal:  Drugs       Date:  2019-06       Impact factor: 9.546

3.  Vascular damage in kidney disease: beyond hypertension.

Authors:  Andréa E M Stinghen; Roberto Pecoits-Filho
Journal:  Int J Hypertens       Date:  2011-08-14       Impact factor: 2.420

4.  The Effects of Combined Exercise on Health-Related Fitness, Endotoxin, and Immune Function of Postmenopausal Women with Abdominal Obesity.

Authors:  Sung-Mo Park; Yi-Sub Kwak; Jin-Goo Ji
Journal:  J Immunol Res       Date:  2015-05-14       Impact factor: 4.818

5.  Increased Hepato-Splanchnic Vasoconstriction in Diabetics during Regular Hemodialysis.

Authors:  Werner Ribitsch; Daniel Schneditz; Casper F M Franssen; Gernot Schilcher; Vanessa Stadlbauer; Jörg H Horina; Alexander R Rosenkranz
Journal:  PLoS One       Date:  2015-12-29       Impact factor: 3.240

6.  A comparative study of blood endotoxin detection in haemodialysis patients.

Authors:  Jonathan Wong; Nathan Davies; Hasan Jeraj; Enric Vilar; Adie Viljoen; Ken Farrington
Journal:  J Inflamm (Lond)       Date:  2016-07-30       Impact factor: 4.981

7.  Is Endotoxemia in Stable Hemodialysis Patients an Artefact? Limitations of the Limulus Amebocyte Lysate Assay and Role of (1→3)-β-D Glucan.

Authors:  Jonathan Wong; Yonglong Zhang; Ashish Patidar; Enric Vilar; Malcolm Finkelman; Ken Farrington
Journal:  PLoS One       Date:  2016-10-20       Impact factor: 3.240

Review 8.  Sevelamer revisited: pleiotropic effects on endothelial and cardiovascular risk factors in chronic kidney disease and end-stage renal disease.

Authors:  Anjay Rastogi
Journal:  Ther Adv Cardiovasc Dis       Date:  2013-12

9.  High Glucose and Lipopolysaccharide Prime NLRP3 Inflammasome via ROS/TXNIP Pathway in Mesangial Cells.

Authors:  Hong Feng; Junling Gu; Fang Gou; Wei Huang; Chenlin Gao; Guo Chen; Yang Long; Xueqin Zhou; Maojun Yang; Shuang Liu; Shishi Lü; Qiaoyan Luo; Yong Xu
Journal:  J Diabetes Res       Date:  2016-01-05       Impact factor: 4.011

Review 10.  Intestinal Barrier Disturbances in Haemodialysis Patients: Mechanisms, Consequences, and Therapeutic Options.

Authors:  D S March; M P M Graham-Brown; C M Stover; N C Bishop; J O Burton
Journal:  Biomed Res Int       Date:  2017-01-17       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.